NYSE · Healthcare · Medical Devices · USA
Inspire Medical Systems Inc is a small cap company (market value between $300 million and $2 billion) in the Medical Devices industry.
Inspire Medical Systems manufactures an implantable device that treats moderate to severe obstructive sleep apnea by delivering electrical stimulation to keep airways open during sleep. The company's proprietary technology uses continuous monitoring to automatically trigger nerve stimulation. It sells the system to hospitals and surgical facilities in the United States and internationally through direct sales representatives and distributors.
From its FY2025 annual report (Form 10-K)
Intrinsic value, DCF valuation, financial health and value investing analysis for the Inspire Medical Systems Inc stock.
Undervalued: intrinsic value $82.70 per share, market price $59.41, margin of safety 28.2% (as of 2026-11-17).
Discounting its cash flows at 8.8% (average of 2 methods) values the shares at $82.70; the price of $59.41 is 28% below that value.
17 more funds hold it; the full list is part of the paid plan.
All 140 Medical Devices stocks
4 more in this industry show a wider margin of safety.
INSP is undervalued (as of the 2026-11-17 close). Discounting its cash flows at 8.8% (average of 2 methods) values the shares at $82.70; the price of $59.41 is 28% below that value.
$82.70 per share (as of the 2026-11-17 close), against a market price of $59.41. That is a margin of safety of 28.2%. The value is the average of the 2 valuation methods that apply to this company, recomputed every night after the US close.